Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
The Association of White Matter Integrity and Psychosis Symptoms in Treatment-resistant and Treatment-responsive Schizophrenia
EF 2023-24
Résumé
Schizophrenia is a severe mental disorder and requires the use of antipsychotic medication for symptomatic control. However, approximately one-third of patients experience treatment resistance; that is, they do not demonstrate a robust response to adequate trials of antipsychotic medication. Thus, it is important to develop reliable biomarker(s) predictive of antipsychotic response to allow for the use of the right medication for the right patient, thereby maximizing the benefits and minimizing the risks of pharmacotherapy. Previous studies suggest that white matter abnormalities are evident in schizophrenia; however, little research has investigated white matter correlates in treatment-resistant schizophrenia. The current study aims to compare white matter integrity in patients with and without treatment-resistant schizophrenia who completed brain diffusion tensor imaging (DTI). White matter integrity in ten anatomical tracts will be selected for analysis based on recent work by Ochi et al. (2020) and we will follow the analytic protocol developed by our group to analyze DTI data. With DTI data from 100 participants (n=50 treatment-responsive, n=50 treatment-resistant), our proposed study is the largest to date using DTI biomarkers to examine treatment resistance in the early stages of the disease process. Additionally, the study will also examine the association of white matter integrity with psychosis symptoms. We will use a novel data-driven approach to predict psychosis symptoms trajectory based on the clustering of DTI measures in implicated anatomical tracts. The results of this study will be of clinical relevance and provide an opportunity to better understand white matter differences in relation to treatment resistance and trajectory symptoms.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506098
Name
Huynh Nhu
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Association of White Matter Integrity and Psychosis Symptoms in Treatment-resistant and Treatment-responsive Schizophrenia
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Diffusion Tensor Imaging (Dti); Magnetic Resonance Imaging (Mri); Psychotic Symptoms; Schizophrenia; White Matter
Abstract
Schizophrenia is a severe mental disorder and requires the use of antipsychotic medication for symptomatic control. However, approximately one-third of patients experience treatment resistance; that is, they do not demonstrate a robust response to adequate trials of antipsychotic medication. Thus, it is important to develop reliable biomarker(s) predictive of antipsychotic response to allow for the use of the right medication for the right patient, thereby maximizing the benefits and minimizing the risks of pharmacotherapy. Previous studies suggest that white matter abnormalities are evident in schizophrenia; however, little research has investigated white matter correlates in treatment-resistant schizophrenia. The current study aims to compare white matter integrity in patients with and without treatment-resistant schizophrenia who completed brain diffusion tensor imaging (DTI). White matter integrity in ten anatomical tracts will be selected for analysis based on recent work by Ochi et al. (2020) and we will follow the analytic protocol developed by our group to analyze DTI data. With DTI data from 100 participants (n=50 treatment-responsive, n=50 treatment-resistant), our proposed study is the largest to date using DTI biomarkers to examine treatment resistance in the early stages of the disease process. Additionally, the study will also examine the association of white matter integrity with psychosis symptoms. We will use a novel data-driven approach to predict psychosis symptoms trajectory based on the clustering of DTI measures in implicated anatomical tracts. The results of this study will be of clinical relevance and provide an opportunity to better understand white matter differences in relation to treatment resistance and trajectory symptoms.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Huynh, Nhu
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~